Fasting Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg

NCT00649597 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg
DRUG: Lotensin HCT® Tablets 20 mg/25 mg

Sponsor

Mylan Pharmaceuticals Inc